Effect of Partial Sleep Deprivation on Immunological System in Peripheral Blood
Effect of Sleep Deprivation on Expression of T Cell Markers in Peripheral Blood of Medical Residents
1 other identifier
observational
50
1 country
1
Brief Summary
Sleep deprivation was found to affect many organs including the immune system and predisposing for various health consequences including diabetes hypertension infections and increase in neoplastic diseases. Subjects will be evaluated for immune parameters in peripheral blood test following a regular nigh sleep and compared with a test performed following a night shift in which they slept less than 3 hours. Each participant will serve as its own control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 25, 2013
CompletedFirst Posted
Study publicly available on registry
August 28, 2013
CompletedStudy Start
First participant enrolled
September 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedAugust 28, 2013
August 1, 2013
1 year
August 25, 2013
August 27, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
surface markers of T cell as assessed by FACS
6 months
serum cytokine levels
6 months
immune parameters to be assessed by western including STAT proteins
6 months
Study Arms (1)
surface markers on T cells as assessed by FACS
Interventions
Eligibility Criteria
Medical residnets
You may qualify if:
- Male and female ages 18-40 signed confirmed consent no evidence of chronic disease or chronic medications
You may not qualify if:
- Any type of acute infection or other acute illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hadassah Medical Organization
Jerusalem, Jerusalem, 91120, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
August 25, 2013
First Posted
August 28, 2013
Study Start
September 1, 2013
Primary Completion
September 1, 2014
Study Completion
September 1, 2014
Last Updated
August 28, 2013
Record last verified: 2013-08